To further promote the construction of a Healthy China planning a new "construction plan", the State Council issued the "Healthy China Initiative (2019-2030)", the program focuses on the current major health problems and factors affecting the two core disease prevention and health promotion.

Cue Health Inc., a healthcare technology company, reported financial results for the fourth quarter and full-year 2022.

On December 28,Shanghai Universal Biotech Co.,Ltd. was listed on the Shenzhen Stock Exchange (SZSE) ChiNext, stock code: 301166. The issue price is 86.06 yuan/share, and the opening price is 92 yuan/share.